Abstract
Gads is a member of the family of SH2 and SH3 domain containing adaptor proteins that is expressed specifically in hematopoietic cells and functions in the coordination of tyrosine kinase mediated signal transduction. Gads plays a critical role in signalling from the T cell receptor by promoting the formation of a complex between SLP-76 and LAT. This complex couples the T cell receptor to Ras through a novel pathway involving PLC-γ1, Tec family kinases, and RasGRP. Studies with Gads-deficient mice have highlighted its importance for thymocyte proliferation during T cell maturation. Emerging evidence suggests that Gads may also play additional roles in antigen-receptor signalling and receptor tyrosine kinase mediated signalling in other hematopoietic lineages. Gads is a unique member of the Grb2 adaptor family, because its activity can be regulated by caspase cleavage. Gads nucleates multi-protein complexes that are required for tyrosine kinase-dependent signalling in immune cells and may also represent a point of modulation for these pathways through the activation of caspase-dependent signalling events.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anafi M, Kiefer F, Gish GD, Mbamalu G, Iscove NN, Pawson T . 1997 J. Biol. Chem. 272: 27804–27811
Asada H, Ishii N, Sasaki Y, Endo K, Kasai H, Tanaka N, Takeshita T, Tsuchiya S, Konno T, Sugamura K . 1999 J. Exp. Med. 189: 1383–1390
Asazuma N, Wilde JI, Berlanga O, Leduc M, Leo A, Schweighoffer E, Tybulewicz V, Bon C, Liu SK, McGlade CJ, Schraven B, Watson SP . 2000 J. Biol. Chem. 275: 33427–33434
Berry DM, Benn SJ, Cheng AM, McGlade CJ . 2001 Oncogene 20: 1203–1211
Bourette RP, Arnaud S, Myles GM, Blanchet JP, Rohrschneider LR, Mouchiroud G . 1998 EMBO J. 17: 7273–7281
Bourgin C, Bourette R, Mouchiroud G, Arnaud S . 2000 FEBS Lett. 480: 113–117
Buday L . 1999 Biochim. Biophys. Acta. 1422: 187–204
Buday L, Downward J . 1993 Cell 73: 611–620
Buday L, Egan SE, Rodriguez Viciana P, Cantrell DA, Downward J . 1994 J. Biol. Chem. 269: 9019–9023
Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, Berg LJ . 2000 J. Biol. Chem. 275: 2219–2230
Cantrell D . 1996 Annu. Rev. Immunol. 14: 259–274
Cheng AM, Saxton TM, Sakai R, Kulkarni S, Mbamalu G, Vogel W, Tortorice CG, Cardiff RD, Cross JC, Muller WJ, Pawson T . 1998 Cell 95: 793–803
Clark SG, Stern MJ, Horvitz HR . 1992 Nature 356: 340–344
Clements JL, Ross-Barta S, Tygrett LT, Waldschmidt TJ, Koretzky GA . 1998a J. Immunol. 161: 3880–3889
Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, Koretzky GA . 1998b Science 281: 416–419
Dower NA, Stang SL, Bottorff DA, Ebinu JO, Dickie P, Ostergaard HL, Stone JC . 2000 Nat. Immunol. 1: 317–321
Downward J, Graves J, Cantrell D . 1992 Immunol. Today 13: 89–92
Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA . 1990 Nature 346: 719–723
Ebinu JO, Stang SL, Teixeira C, Bottorff DA, Hooton J, Blumberg PM, Barry M, Bleakley RC, Ostergaard HL, Stone JC . 2000 Blood 95: 3199–3203
Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA . 1993 Nature 363: 45–51
Ellis JH, Ashman C, Burden MN, Kilpatrick KE, Morse MA, Hamblin PA . 2000 J. Immunol. 164: 5805–5814
Ellmeier W, Sawada S, Littman DR . 1999 Annu. Rev. Immunol. 17: 523–554
Feng GS, Ouyang YB, Hu DP, Shi ZQ, Gentz R, Ni J . 1996 J. Biol. Chem. 271: 12129–12132
Fu C, Turck CW, Kurosaki T, Chan AA . 1998 Immunity 9: 93–103
Gobel TW, Bolliger L . 2000 Curr. Top. Microbiol. Immunol. 248: 303–320
Gong Q, Cheng AM, Akk AM, Alberola-Ila J, Gong G, Pawson T, Chan AC . 2001 Nat. Immunol. 2: 29–36
Ishiai M, Kurosaki M, Inabe K, Chan AC, Sugamura K, Kurosaki T . 2000 J. Exp. Med. 192: 847–856
Jackman JK, Motto DG, Sun QM, Tanemoto M, Turck CW, Pelz GA, Koretzky GA, Findell PR . 1995 J. Biol. Chem. 270: 7029–7032
Kawasaki H, Springett GM, Toki S, Canales JJ, Harlan P, Blumenstiel JP, Chen EJ, Bany IA, Mochizuki N, Ashbacher A, Matsuda M, Housman DE, Graybiel AM . 1998 Proc. Natl. Acad. Sci. USA 95: 13278–13283
Kiefer F, Tibbles LA, Anafi M, Janssen A, Zanke BW, Lassam N, Pawson T, Woodgett JR, Iscove NN . 1996 EMBO J. 15: 7013–7025
Kikuchi K, Kawasaki Y, Ishii N, Sasaki Y, Asao H, Takeshita T, Miyoshi I, Kasai N, Sugamura K . 2001 Int. Immunol. 13: 777–783
Law CL, Ewings MK, Chaudhary PM, Solow SA, Yun TJ, Marshall AJ, Hood L, Clark EA . 1999 J. Exp. Med. 189: 1243–1253
Lewitzky M, Kardinal C, Gehring NH, Schmidt EK, Konkol B, Eulitz M, Birchmeier W, Schaeper U, Feller SM . 2001 Oncogene 20: 1052–1062
Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B, Schlessinger J . 1993 Nature 363: 85–88
Liu SK, Fang N, Koretzky GA, McGlade CJ . 1999 Curr. Biol. 9: 67–75
Liu SK, McGlade CJ . 1998 Oncogene 17: 3073–3082
Liu SK, Smith CA, Arnold R, Kiefer F, McGlade CJ . 2000 J. Immunol. 165: 1417–1426
Lock LS, Royal I, Naujokas MA, Park M . 2000 J. Biol. Chem. 275: 31536–31545
Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J . 1992 Cell 70: 431–442
Ma W, Xia C, Ling P, Qiu M, Luo Y, Tan TH, Liu M . 2001 Oncogene 20: 1703–1714
Myung PS, Boerthe NJ, Koretzky GA . 2000 Curr. Opin. Immunol. 12: 256–266
Olivier JP, Raabe T, Henkemeyer M, Dickson B, Mbamalu G, Margolis B, Schlessinger J, Hafen E, Pawson T . 1993 Cell 73: 179–191
Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML . 1993 Cell 75: 175–185
Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, Geha RS . 1998 Cell 94: 229–238
Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T . 1994 EMBO J. 13: 764–773
Qiu M, Hua S, Agrawal M, Li G, Cai J, Chan E, Zhou H, Luo Y, Liu M . 1998 Biochem. Biophys. Res. Commun. 253: 443–447
Rayter SI, Woodrow M, Lucas SC, Cantrell DA, Downward J . 1992 EMBO J. 11: 4549–4556
Reif K, Buday L, Downward J, Cantrell DA . 1994 J. Biol. Chem. 269: 14081–14087
Roose J, Weiss A . 2000 Nat. Immunol. 1: 275–276
Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D . 1993 Nature 363: 83–85
Sastry L, Lin WH, Wong WT, DiFiore PP, Scoppa CA, King CR . 1995 Oncogene 11: 1107–1112
Sawyers CL . 1999 N. Engl. J. Med. 340: 1330–1340
Schneider H, Guerette B, Guntermann C, Rudd CE . 2000 J. Biol. Chem. 275: 3835–3840
Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS . 1999 Annu. Rev. Immunol. 17: 829–874
Sieh M, Batzer A, Schlessinger J, Weiss A . 1994 Mol. Cell. Biol. 14: 4435–4442
Simon JA, Schreiber SL . 1995 Chem. Biol. 2: 53–60
Su YW, Zhang Y, Schweikert J, Koretzky GA, Reth M, Wienands J . 1999 Eur. J. Immunol. 29: 3702–3711
Tauchi T, Boswell HS, Leibowitz D, Broxmeyer HE . 1994 J. Exp. Med. 179: 167–175
Topham MK, Prescott SM . 2001 J. Cell. Biol. 152: 1135–1143
Trub T, Frantz JD, Miyazaki M, Band H, Shoelson SE . 1997 J. Biol. Chem. 272: 894–902
Weber JR, Orstavik S, Torgersen KM, Danbolt NC, Berg SF, Ryan JC, Tasken K, Imboden JB, Vaage JT . 1998 J. Exp. Med. 187: 1157–1161
Weiss A, Littman DR . 1994 Cell 76: 263–274
Woodrow MA, Rayter S, Downward J, Cantrell DA . 1993 J. Immunol. 150: 3853–3861
Yankee TM, Draves KE, Ewings MK, Clark EA . 2001 Proc. Natl. Acad. Sci. 98: 6789–6793
Yoder J, Pham C, Iizuka YM, Kanagawa O, Liu SK, McGlade J, Cheng AM . 2001 Science 291: 1987–1991
Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE . 1998 Cell 92: 83–92
Zhang W, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, Trible RP, Grinberg A, Tsay HC, Jacobs HM, Kessler CM, Long EO, Love PE, Samelson LE . 1999 Immunity 10: 323–332
Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, Samelson LE . 2000 J. Biol. Chem. 275: 23355–23361
Zuniga-Pflucker JC, Lenardo MJ . 1996 Curr. Opin. Immunol. 8: 215–224
Acknowledgements
We would like to thank Alec Cheng, Thomas Yankee, Edward Clark, Kazuo Sugamura and Guy Mouchiroud for communicating results prior to publication. We also acknowledge the support of the Cancer Research Society, Inc., Canada, and the Canadian Institutes of Health Research. CJ McGlade is a Research Scientist of the National Cancer Institute of Canada supported by funds from the Canadian Cancer Society.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, SW., Berry, D. & McGlade, C. The role of Gads in hematopoietic cell signalling. Oncogene 20, 6284–6290 (2001). https://doi.org/10.1038/sj.onc.1204771
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204771
Keywords
This article is cited by
-
Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
Arthritis Research & Therapy (2015)
-
Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemia
Leukemia (2013)
-
C terminus of the P2X7 receptor: treasure hunting
Purinergic Signalling (2011)
-
Efficient T-cell receptor signaling requires a high-affinity interaction between the Gads C-SH3 domain and the SLP-76 RxxK motif
The EMBO Journal (2007)
-
Recruitment and activation of PLCγ1 in T cells: a new insight into old domains
The EMBO Journal (2006)